Asset sale Completed

Bora Pharmaceuticals Co. acquisition of MacroGenics GMP manufacturing site and CDMO operations

US$123m consideration

Announced 11 May 2026

Advisers

MacroGenics GMP manufacturing site and CDMO operations

Target

Financial adviser

Bora Pharmaceuticals Co.

Acquirer

Legal adviser
Target
MacroGenics GMP manufacturing site and CDMO operations
Acquirer
Bora Pharmaceuticals Co.
Seller
MacroGenics
Target based in
United States
Buyer based in
Taiwan
Seller based in
United States
Completed
2 Jul 2026
Sector
Pharmaceutical Manufacturing
Tags
Pharmaceutical Manufacturing, Contract Manufacturing, Pharma Services

In the league tables

Similar deals

All pharmaceutical manufacturing deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.